Pharma channel feed

Q&A: FTC’s top health­care en­forcer on phar­ma M&A, com­pa­ny growth and PBMs

Last year
Deals
FDA+

FDA ap­proves Am­gen’s T cell en­gager in ag­gres­sive form of lung can­cer

Last year
FDA+

GSK plans to sell off re­main­ing stake in con­sumer spin­out Ha­le­on

Last year
Deals

Phar­ma is re­think­ing how it in­ter­acts with pa­tients af­ter Eli Lil­ly ripped up the play­book

Last year
Health Tech

Roche was in 'ad­vanced' talks to out-li­cense its An­gel­man syn­drome drug, but po­ten­tial part­ner with­drew

Last year
Deals
R&D

House pan­el ad­vances bills tar­get­ing rare dis­ease, pri­or­i­ty re­view vouch­ers

Last year
FDA+

Bris­tol My­er­s' CAR-T ther­a­py Breyanzi adds fol­lic­u­lar lym­phoma to list of ap­provals

Last year
Cell/Gene Tx
FDA+

GSK, UK gov­ern­ment bud­get £130M to fight glob­al an­timi­cro­bial re­sis­tance

Last year
Financing

BeiGene looks at new part­ner­ships, with a full can­cer pipeline and grow­ing foot­print

Last year
Deals
China

Eli Lil­ly set­tles with med­ical spa over its mar­ket­ing of com­pound­ed tirzepatide

Last year
Law

WHO green­lights Takeda's dengue vac­cine as com­pa­ny plans to 're-en­gage' with FDA

Last year
FDA+

House com­mit­tee ad­vances bi­par­ti­san bill tar­get­ing Chi­nese biotech sup­pli­ers

Last year

As ad­comm looms, ICER rais­es ques­tions over Lykos’ MD­MA stud­ies

Last year
FDA+

GoodRx gets back in Kroger's good graces, will work di­rect­ly with gro­cer

Last year
Health Tech

Ei­sai projects near-term Leqem­bi sales 'con­sid­er­ably high­er' than an­a­lyst fore­casts

Last year

Ei­sai heads to FDA with sub­cu­ta­neous ver­sion of Alzheimer’s treat­ment de­vel­oped with Bio­gen

Last year
FDA+

As­cendis’ hy­poparathy­roidism drug sad­dled with three-month de­lay at FDA

Last year
FDA+

De­struc­tion of doc­u­ments, in­suf­fi­cient da­ta lead FDA to re­ject hep B vac­cine up­date

Last year
FDA+

Bay­er cuts 1,500 staffers com­pa­ny­wide in cam­paign to re­duce bu­reau­cra­cy

Last year
R&D

Pfiz­er sub­mits trade­mark ap­pli­ca­tion that sug­gests it could be launch­ing a di­rect-to-pa­tient pro­gram

Last year
Health Tech

Ab­b­Vie goes deep­er in­to neu­ro­science with col­lab­o­ra­tion worth as much as $2B

Last year
Deals

WHO mem­bers miss dead­line for pan­dem­ic ac­cord draft, will con­tin­ue talks

Last year
FDA+

Size of 340B mar­ket triples since 2018 and may dou­ble again, re­port says

Last year

Cy­to­ki­net­ics lifts cur­tain on Phase 3 afi­camten da­ta, com­mer­cial launch prep un­der­way

Last year
R&D
First page Previous page 55565758596061 Next page Last page
A service from the Financial Times